408 related articles for article (PubMed ID: 29970906)
1. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
3. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract][Full Text] [Related]
4. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
5. HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/
Ma HM; Zhang Q; Yang XM; Hu Y; Zhang J; Chen L; Zhao B; Yang WT; Xu R
Oxid Med Cell Longev; 2022; 2022():8168988. PubMed ID: 35132353
[TBL] [Abstract][Full Text] [Related]
6. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
7. DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.
Liu XF; Li XY; Zheng PS; Yang WT
Cell Death Dis; 2018 Mar; 9(3):339. PubMed ID: 29497051
[TBL] [Abstract][Full Text] [Related]
8. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
9. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
10. HOXA5 inhibits the proliferation and neoplasia of cervical cancer cells via downregulating the activity of the Wnt/β-catenin pathway and transactivating TP53.
Ma HM; Cui N; Zheng PS
Cell Death Dis; 2020 Jun; 11(6):420. PubMed ID: 32499530
[TBL] [Abstract][Full Text] [Related]
11. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway.
Chen Q; Cao HZ; Zheng PS
Oncotarget; 2014 Oct; 5(19):9092-105. PubMed ID: 25193857
[TBL] [Abstract][Full Text] [Related]
12. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.
Cui N; Yang WT; Zheng PS
Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045
[TBL] [Abstract][Full Text] [Related]
13. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
[TBL] [Abstract][Full Text] [Related]
14. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
15. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.
Chen HL; Chew LJ; Packer RJ; Gallo V
Cancer Lett; 2013 Jul; 335(2):361-71. PubMed ID: 23474492
[TBL] [Abstract][Full Text] [Related]
17. Sox17 and β-catenin co-occupy Wnt-responsive enhancers to govern the endoderm gene regulatory network.
Mukherjee S; Chaturvedi P; Rankin SA; Fish MB; Wlizla M; Paraiso KD; MacDonald M; Chen X; Weirauch MT; Blitz IL; Cho KW; Zorn AM
Elife; 2020 Sep; 9():. PubMed ID: 32894225
[TBL] [Abstract][Full Text] [Related]
18. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
Yang F; Xiao Z; Zhang S
Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]